• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Hemangioblastoma Companies

    ID: MRFR/Pharma/4943-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Hemangioblastoma companies specialize in addressing hemangioblastomas, vascular tumors often found in the central nervous system. These companies contribute to neurosurgery and oncology by providing diagnostic tools, imaging technologies, and treatment options, including surgical interventions, for managing hemangioblastomas.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Hemangioblastoma Market

    Hemangioblastoma Key CompaniesLatest Hemangioblastoma Companies Update

    Medtronic and BrainLab companies offer advanced neurosurgical equipment and imaging technologies used in Hemangioblastoma diagnosis and surgery, potentially benefiting from increasing demand for these procedures.


    Siemens Healthineers their advancements in MRI technology provide improved visualization of brain tumors, including Hemangioblastomas, contributing to earlier diagnosis and better treatment planning.


    Small Biotechs companies like Viela Bio and BlueRock Therapeutics are exploring gene therapy approaches for brain tumors, which could potentially benefit Hemangioblastoma patients in the future.List of Hemangioblastoma Key Companies in the Market



    • Eli Lilly and Company

    • Bedford Laboratories

    • Astellas US Holding, Inc.

    • DNAtrix, Inc.

    • Advantagene, Inc

    • Burzynski Research Institute, Inc.

    • Direct Therapeutics, Inc.

    • Cellectar Biosciences, Inc